Retrospective Study
Copyright ©The Author(s) 2017.
World J Clin Oncol. Aug 10, 2017; 8(4): 343-350
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.343
Table 1 Indications and contraindications of trans-arterial chemoperfusion
Indications
Unresectable liver metastases
Liver-dominant metastatic disease
Minimum of three different chemotherapies before
No systemic chemotherapy available
Symptomatic liver metastases
Contraindications
ECOG >1
Tumour burden of the liver > 75%
Poor liver function (quick < 40%, PTT < 45 s, albumin < 2 g/dL)
Extensive amounts of ascites
Obstructive icterus (bilirubin > 3 mg/dL)
Acute infection
Myelodepression (leucocytes < 2000/mL, platelets < 100000/μL)
Limited kidney function (creatinine > 2 mg/dL)
Extensive heart insufficiency ( > NYHA II)